<p><span style="font-size:11pt"><span style="font-family:Arial,sans-serif">Dr. Colleen A. Hanlon is a professor in the Department of Cancer Biology at Wake Forest University Health Sciences, wherein she <span style="color:black">leads a new Electromagnetic Therapeutics Research Program. The majority of her research is focused on developing evidence-based TMS protocols which may be useful therapeutic tools for patients struggling with addiction. She leads 3 NIH-supported R01 awards and is part of two NIH centers interested in translating preclinical brain stimulation knowledge into a treatment that can be delivered to patients with alcohol and substance use disorders.&nbsp;&nbsp; She was honored with the Early Career Investigator award from the National Institute of Drug Abuse.&nbsp; She has over 75 publications highlighting the breadth of her research experience in neuroimaging and&nbsp;brain stimulation. These include&nbsp;studies&nbsp;in nonhuman primates,&nbsp; imaging and brain stimulation methods development manuscripts, and published clinical trials.&nbsp; She is the senior author on the first &ldquo;Consensus Paper&rdquo; outlining the path forward for Non-Invasive Therapeutic Development for Addiction.</span></span></span></p><p><span style="font-size:11pt"><span style="font-family:Arial,sans-serif"><span style="color:black">She loves science and being a scientist&ndash; the process and the privilege.&nbsp; Perhaps more than the actual data analysis and writing however, she is finds a unique joy in mentoring and nurturing the creative ideas among her students and her colleagues.&nbsp;&nbsp; She participates in the research training and education community at both a local level (serving as a mentor to over 50 medical, graduate, post-graduate, and fellowship trainees since 2005 on a national and international scale) and national level. She </span>has directed the Advanced TMS Training Course sponsored by the National Center for Neuromodulation for Rehabilitation, <span style="color:black">and continues to be involved in their research dissemination efforts through teaching and management of their social media presence.&nbsp; She has led an annual addiction outreach event at the College of Problems on Drug Dependence (CPDD) meeting (2015-2019), served on the Liaison Committee (2016-2019) and the Education and Training Committee (2019-present)&nbsp; for the American College of Neuropsychopharmacology, Grassroots Advocacy Team for the Society for Neuroscience (2017-2019), Chair of the Education Outreach and Public Policy Committee for CPDD (2017-2019), ad hoc participation in over 20 NIH study sections, and serving as a standing member of NIH NPAS study section (effective 10/2018).&nbsp;&nbsp;&nbsp; </span></span></span></p><p>&nbsp;</p>